XML 63 R51.htm IDEA: XBRL DOCUMENT v3.25.3
Shareholders’ Equity and Equity Compensation - Schedule of Share-Based Payment Arrangement, Option, Activity (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 9 Months Ended 12 Months Ended
Mar. 03, 2025
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Dec. 31, 2024
Number of Options            
Beginning balance (in shares)       21,770,225    
Granted (in shares) 1,530,000     3,085,295    
Exercised (in shares)       (1,287,294)    
Forfeited or expired (in shares)       (897,662)    
Ending balance (in shares)   22,670,564   22,670,564   21,770,225
Total exercisable (in share)   16,656,509   16,656,509    
Total vested or expected to vest (in shares)   21,841,290   21,841,290    
Weighted Average Exercise Price Per Share            
Beginning balance (in dollars per share)       $ 9.06    
Granted (in dollars per share) $ 18.60     18.79    
Exercised (in dollars per share)       6.13    
Forfeited or expired (in dollars per share)       13.49    
Ending balance (in dollars per share)   $ 10.38   10.38   $ 9.06
Total exercisable (in dollars per share)   7.74   7.74    
Total vested or expected to vest (in dollars per share)   $ 10.09   $ 10.09    
Weighted Average Remaining Contract Term            
Total outstanding as of December 31, 2024:       5 years 2 months 15 days   5 years 4 months 24 days
Total outstanding as of September 30, 2025       5 years 2 months 15 days   5 years 4 months 24 days
Total exercisable as of September 30, 2025       4 years 2 months 15 days    
Total vested or expected to vest as of September 30, 2025       5 years 1 month 6 days    
Aggregate Intrinsic Value            
Total outstanding as of December 31, 2024:       $ 226,117    
Exercised   $ 8,700 $ 1,100 13,500 $ 2,600  
Total outstanding as of September 30, 2025   450,463   450,463   $ 226,117
Total exercisable as of September 30, 2025   374,980   374,980    
Total vested or expected to vest as of September 30, 2025   $ 440,333   $ 440,333